Liberia & Guinea’s $5B Leap with Liberty Corridor: A Game-Changerby John Darbie 12.02.2024Mining billionaire Robert Friedland's company, HPX, is partnering with Liberia's government and Guma Africa Group for a $5 billion infrastructure ...
PepsiCo’s New Forecast: A Refreshing Buy Opportunity?by Mark Eisenberg 12.02.2024PepsiCo lowers organic sales growth forecast, but Citi upgrades stock rating and raises price target due to positive market expectations.
Cidara Therapeutics: $11.1M European Approval Milestoneby Mark Eisenberg 12.02.2024Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
AGF Management Expands Alternatives Business with New Holland Stakeby Mark Eisenberg 12.02.2024Canadian asset management firm AGF Management has made a strategic investment in New York-based investment manager New Holland Capital as ...
Trade Desk Inc: Revenue Concerns Prompt Sell Ratingby Mark Eisenberg 12.02.2024Benchmark analysts maintain their Sell rating for The Trade Desk Inc. due to revenue concerns and predict a possible stock ...
Uber Surpasses Profit Expectations in 14th Yearby Mark Eisenberg 12.02.2024Uber reports first annual profit in 14 years, beating analyst estimates. Gross bookings and total trips taken showed significant growth. ...
GRANOLAS Stocks Outperform Tech Titansby Mark Eisenberg 12.02.2024European blue-chip stocks known as the GRANOLAS group have outperformed the Magnificent 7 in the European market, accounting for 60% ...
Bank of America Analysts: Small-Caps the Market’s Hidden Gemby Mark Eisenberg 12.02.2024Despite the market rally, small-cap stocks have become cheaper, making them an attractive option for investors. Bank of America analysts ...
Shell’s Bonny Terminal Fuels Nigeria’s Refinery Revival.by Mark Eisenberg 12.02.2024Shell Nigeria has resumed oil supply to the Port Harcourt Refinery after a five-year outage, reducing the country's dependence on ...
Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pactby Mark Eisenberg 12.02.2024Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...